Skip to main content
Top
Published in: World Journal of Surgery 10/2014

01-10-2014

High Survival in Patients Operated for Small Isolated Liver Metastases from Gastric Cancer: A Multi-institutional Study

Authors: Koji Komeda, Michihiro Hayashi, Shoji Kubo, Hiroaki Nagano, Takuya Nakai, Masaki Kaibori, Hiroshi Wada, Shigekazu Takemura, Masahiko Kinoshita, Chikato Koga, Masataka Matsumoto, Tatsuma Sakaguchi, Yoshihiro Inoue, Fumitoshi Hirokawa, A-Hon Kwon, Kazuhisa Uchiyama

Published in: World Journal of Surgery | Issue 10/2014

Login to get access

Abstract

Background

Although several studies have reported the outcomes of surgery for the treatment of liver metastases of gastric cancer (GLM), indications for liver resection for gastric metastases remain controversial. This study was designed to identify prognostic determinants that identify operable hepatic metastases from gastric cancer and to evaluate the actual targets of surgical therapy.

Methods

Retrospective analysis was performed on outcomes for 24 consecutive patients at five institutions who underwent gastrectomy for gastric cancer followed by curative hepatectomy for GLM between 2000 and June 2012.

Results

Overall 5-year survival and median survival were 40.1 % and 22.3 months, respectively. Uni- and multivariate analyses showed that liver metastatic tumour size less than 5 cm was the most important predictor of overall survival (OS, p = 0.03). Four patients survived >5 years. Repeat hepatectomy was performed in three patients. Two of these patients have remained disease-free since the repeat hepatectomy.

Conclusions

GLM patients with metastatic tumour diameter less than 5 cm maximum are the best candidates for hepatectomy. Hepatic resection should be considered as an option for gastric cancer patients with liver metastases.
Literature
1.
go back to reference Kokudo N, Tada K, Seki M et al (2001) Anatomical major resection versus nonanatomical limited resection for liver metastases from colorectal carcinoma. Am J Surg 181:153–159PubMedCrossRef Kokudo N, Tada K, Seki M et al (2001) Anatomical major resection versus nonanatomical limited resection for liver metastases from colorectal carcinoma. Am J Surg 181:153–159PubMedCrossRef
2.
go back to reference Choti MA, Sitzmann JV, Tiburi MF et al (2002) Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235:759–766PubMedCrossRefPubMedCentral Choti MA, Sitzmann JV, Tiburi MF et al (2002) Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235:759–766PubMedCrossRefPubMedCentral
3.
go back to reference Abdalla EK, Vauthey JN, Ellis LM et al (2004) Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239:818–825; discussion 817–825 Abdalla EK, Vauthey JN, Ellis LM et al (2004) Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239:818–825; discussion 817–825
4.
go back to reference Pawlik TM, Scoggins CR, Zorzi D et al (2005) Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241:715–722; discussion 714–722 Pawlik TM, Scoggins CR, Zorzi D et al (2005) Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241:715–722; discussion 714–722
5.
go back to reference Rees M, Tekkis PP, Welsh FK et al (2008) Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg 247:125–135PubMedCrossRef Rees M, Tekkis PP, Welsh FK et al (2008) Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg 247:125–135PubMedCrossRef
6.
go back to reference de Jong MC, Pulitano C, Ribero D et al (2009) Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. Ann Surg 250:440–448PubMed de Jong MC, Pulitano C, Ribero D et al (2009) Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. Ann Surg 250:440–448PubMed
7.
go back to reference Ochiai T, Sasako M, Mizuno S et al (1994) Hepatic resection for metastatic tumours from gastric cancer: analysis of prognostic factors. Br J Surg 81:1175–1178PubMedCrossRef Ochiai T, Sasako M, Mizuno S et al (1994) Hepatic resection for metastatic tumours from gastric cancer: analysis of prognostic factors. Br J Surg 81:1175–1178PubMedCrossRef
8.
go back to reference Saiura A, Umekita N, Inoue S et al (2002) Clinicopathological features and outcome of hepatic resection for liver metastasis from gastric cancer. Hepatogastroenterology 49:1062–1065PubMed Saiura A, Umekita N, Inoue S et al (2002) Clinicopathological features and outcome of hepatic resection for liver metastasis from gastric cancer. Hepatogastroenterology 49:1062–1065PubMed
9.
go back to reference Sakamoto Y, Ohyama S, Yamamoto J et al (2003) Surgical resection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients. Surgery 133:507–511PubMedCrossRef Sakamoto Y, Ohyama S, Yamamoto J et al (2003) Surgical resection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients. Surgery 133:507–511PubMedCrossRef
10.
go back to reference Koga R, Yamamoto J, Ohyama S et al (2007) Liver resection for metastatic gastric cancer: experience with 42 patients including eight long-term survivors. Jpn J Clin Oncol 37:836–842PubMedCrossRef Koga R, Yamamoto J, Ohyama S et al (2007) Liver resection for metastatic gastric cancer: experience with 42 patients including eight long-term survivors. Jpn J Clin Oncol 37:836–842PubMedCrossRef
11.
go back to reference Cheon SH, Rha SY, Jeung HC et al (2008) Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases. Ann Oncol 19:1146–1153PubMedCrossRef Cheon SH, Rha SY, Jeung HC et al (2008) Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases. Ann Oncol 19:1146–1153PubMedCrossRef
13.
go back to reference Tiberio GA, Coniglio A, Marchet A et al (2009) Metachronous hepatic metastases from gastric carcinoma: a multicentric survey. Eur J Surg Oncol 35:486–491PubMedCrossRef Tiberio GA, Coniglio A, Marchet A et al (2009) Metachronous hepatic metastases from gastric carcinoma: a multicentric survey. Eur J Surg Oncol 35:486–491PubMedCrossRef
14.
go back to reference Maehara Y, Moriguchi S, Kakeji Y et al (1991) Prognostic factors in adenocarcinoma in the upper one-third of the stomach. Surg Gynecol Obstet 173:223–226PubMed Maehara Y, Moriguchi S, Kakeji Y et al (1991) Prognostic factors in adenocarcinoma in the upper one-third of the stomach. Surg Gynecol Obstet 173:223–226PubMed
15.
go back to reference Miyazaki M, Itoh H, Nakagawa K et al (1997) Hepatic resection of liver metastases from gastric carcinoma. Am J Gastroenterol 92:490–493PubMed Miyazaki M, Itoh H, Nakagawa K et al (1997) Hepatic resection of liver metastases from gastric carcinoma. Am J Gastroenterol 92:490–493PubMed
16.
go back to reference Ambiru S, Miyazaki M, Ito H et al (2001) Benefits and limits of hepatic resection for gastric metastases. Am J Surg 181:279–283PubMedCrossRef Ambiru S, Miyazaki M, Ito H et al (2001) Benefits and limits of hepatic resection for gastric metastases. Am J Surg 181:279–283PubMedCrossRef
18.
go back to reference Shirabe K, Shimada M, Matsumata T et al (2003) Analysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection: a multi-institutional study of the indications for resection. Hepatogastroenterology 50:1560–1563PubMed Shirabe K, Shimada M, Matsumata T et al (2003) Analysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection: a multi-institutional study of the indications for resection. Hepatogastroenterology 50:1560–1563PubMed
19.
go back to reference Sakamoto Y, Sano T, Shimada K et al (2007) Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer. J Surg Oncol 95:534–539PubMedCrossRef Sakamoto Y, Sano T, Shimada K et al (2007) Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer. J Surg Oncol 95:534–539PubMedCrossRef
20.
go back to reference Tsujimoto H, Ichikura T, Ono S et al (2010) Outcomes for patients following hepatic resection of metastatic tumors from gastric cancer. Hepatol Int 4:406–413PubMedCrossRefPubMedCentral Tsujimoto H, Ichikura T, Ono S et al (2010) Outcomes for patients following hepatic resection of metastatic tumors from gastric cancer. Hepatol Int 4:406–413PubMedCrossRefPubMedCentral
21.
go back to reference Takemura N, Saiura A, Koga R et al (2012) Long-term outcomes after surgical resection for gastric cancer liver metastasis: an analysis of 64 macroscopically complete resections. Langenbecks Arch Surg 397:951–957PubMedCrossRef Takemura N, Saiura A, Koga R et al (2012) Long-term outcomes after surgical resection for gastric cancer liver metastasis: an analysis of 64 macroscopically complete resections. Langenbecks Arch Surg 397:951–957PubMedCrossRef
22.
go back to reference Maehara Y, Moriguchi S, Kakeji Y et al (1991) Pertinent risk factors and gastric carcinoma with synchronous peritoneal dissemination or liver metastasis. Surgery 110:820–823PubMed Maehara Y, Moriguchi S, Kakeji Y et al (1991) Pertinent risk factors and gastric carcinoma with synchronous peritoneal dissemination or liver metastasis. Surgery 110:820–823PubMed
23.
go back to reference Nordlinger B, Guiguet M, Vaillant JC et al (1996) Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 77:1254–1262PubMedCrossRef Nordlinger B, Guiguet M, Vaillant JC et al (1996) Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 77:1254–1262PubMedCrossRef
24.
go back to reference Fong Y, Fortner J, Sun RL et al (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230:309–318; discussion 318–321 Fong Y, Fortner J, Sun RL et al (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230:309–318; discussion 318–321
25.
go back to reference Nagashima I, Takada T, Matsuda K et al (2004) A new scoring system to classify patients with colorectal liver metastases: proposal of criteria to select candidates for hepatic resection. J Hepatobiliary Pancreat Surg 11:79–83PubMedCrossRef Nagashima I, Takada T, Matsuda K et al (2004) A new scoring system to classify patients with colorectal liver metastases: proposal of criteria to select candidates for hepatic resection. J Hepatobiliary Pancreat Surg 11:79–83PubMedCrossRef
26.
go back to reference Hwang JE, Kim SH, Jin J et al (2014) Combination of percutaneous radiofrequency ablation and systemic chemotherapy are effective treatment modalities for metachronous liver metastases from gastric cancer. Clin Exp Metastasis 31:25–32 Hwang JE, Kim SH, Jin J et al (2014) Combination of percutaneous radiofrequency ablation and systemic chemotherapy are effective treatment modalities for metachronous liver metastases from gastric cancer. Clin Exp Metastasis 31:25–32
27.
go back to reference Chen MH, Yang W, Yan K et al (2005) Treatment efficacy of radiofrequency ablation of 338 patients with hepatic malignant tumor and the relevant complications. World J Gastroenterol 28:6395–6401 Chen MH, Yang W, Yan K et al (2005) Treatment efficacy of radiofrequency ablation of 338 patients with hepatic malignant tumor and the relevant complications. World J Gastroenterol 28:6395–6401
28.
go back to reference Pinson CW, Wright JK, Chapman WC et al (1996) Repeat hepatic surgery for colorectal cancer metastasis to the liver. Ann Surg 223:765–773; discussion 766–773 Pinson CW, Wright JK, Chapman WC et al (1996) Repeat hepatic surgery for colorectal cancer metastasis to the liver. Ann Surg 223:765–773; discussion 766–773
29.
go back to reference Yamamoto J, Kosuge T, Shimada K et al (1999) Repeat liver resection for recurrent colorectal liver metastases. Am J Surg 178:275–281PubMedCrossRef Yamamoto J, Kosuge T, Shimada K et al (1999) Repeat liver resection for recurrent colorectal liver metastases. Am J Surg 178:275–281PubMedCrossRef
30.
go back to reference Brachet D, Lermite E, Rouquette A et al (2009) Prognostic factors of survival in repeat liver resection for recurrent colorectal metastases: review of sixty-two cases treated at a single institution. Dis Colon Rectum 52:475–483PubMedCrossRef Brachet D, Lermite E, Rouquette A et al (2009) Prognostic factors of survival in repeat liver resection for recurrent colorectal metastases: review of sixty-two cases treated at a single institution. Dis Colon Rectum 52:475–483PubMedCrossRef
31.
go back to reference de Jong MC, Mayo SC, Pulitano C et al (2009) Repeat curative intent liver surgery is safe and effective for recurrent colorectal liver metastasis: results from an international multi-institutional analysis. J Gastrointest Surg 13:2141–2151PubMedCrossRef de Jong MC, Mayo SC, Pulitano C et al (2009) Repeat curative intent liver surgery is safe and effective for recurrent colorectal liver metastasis: results from an international multi-institutional analysis. J Gastrointest Surg 13:2141–2151PubMedCrossRef
33.
go back to reference Koizumi W, Narahara H, Hara T et al (2008) S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol 9:215–221PubMedCrossRef Koizumi W, Narahara H, Hara T et al (2008) S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol 9:215–221PubMedCrossRef
34.
go back to reference Boku N, Yamamoto S, Fukuda H et al (2009) Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study. Lancet Oncol 10:1063–1069PubMedCrossRef Boku N, Yamamoto S, Fukuda H et al (2009) Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study. Lancet Oncol 10:1063–1069PubMedCrossRef
35.
go back to reference Bang YJ, Van Cutsem E, Feyereislova A et al (2010) Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 376:687–697PubMedCrossRef Bang YJ, Van Cutsem E, Feyereislova A et al (2010) Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 376:687–697PubMedCrossRef
36.
go back to reference Cunningham D, Okines AF, Ashley S (2010) Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med 362:858–859PubMedCrossRef Cunningham D, Okines AF, Ashley S (2010) Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med 362:858–859PubMedCrossRef
Metadata
Title
High Survival in Patients Operated for Small Isolated Liver Metastases from Gastric Cancer: A Multi-institutional Study
Authors
Koji Komeda
Michihiro Hayashi
Shoji Kubo
Hiroaki Nagano
Takuya Nakai
Masaki Kaibori
Hiroshi Wada
Shigekazu Takemura
Masahiko Kinoshita
Chikato Koga
Masataka Matsumoto
Tatsuma Sakaguchi
Yoshihiro Inoue
Fumitoshi Hirokawa
A-Hon Kwon
Kazuhisa Uchiyama
Publication date
01-10-2014
Publisher
Springer US
Published in
World Journal of Surgery / Issue 10/2014
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-014-2608-x

Other articles of this Issue 10/2014

World Journal of Surgery 10/2014 Go to the issue